Perpetuals.com extends BayesShield AI into healthcare

Perpetuals.com (PDC) announced the extension of its proprietary BayesShield AI technology into healthcare. BayesShield Clinical applies the same patent-pending methodology the company developed to predict trading outcomes to a new domain: identifying which physicians in hospitals and clinics are the most accurate at diagnosing specific types of cases to ensure patients get the best health outcomes. BayesShield Clinical is designed for hospitals, clinics, and health systems. It does not diagnose patients or replace physician judgment. Instead, it strips away behavioral biases, applying statistical methods to identify patterns of diagnostic strength across specific case types. Hospitals and other health care providers can use these insights for optimized case routing, second-opinion protocols, and training program design. Financial markets and clinical medicine share a common analytical problem: decisions made under uncertainty, where skill is obscured by noise, variable conditions, and behavioral bias. The company believes the same approach that identifies performance patterns in financial markets can reveal them in clinical decision-making. Perpetuals has partnered with the European Institute of Management to support the clinical implementation of BayesShield Clinical. Under the arrangement, Perpetuals provides the software platform while EIM works directly with partner hospitals and clinics to manage pilot deployment, trial design, and academic oversight. EIM’s PhD in Healthcare Studies program will serve as the academic collaboration for the clinical pilots, with doctoral candidates contributing to the study design and analysis of outcomes.